Zhejiang Jingxin Pharmaceutical Co., Ltd. (SHE:002020)
China flag China · Delayed Price · Currency is CNY
16.64
+0.01 (0.06%)
Feb 3, 2026, 3:04 PM CST

SHE:002020 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
452.28316.271,4611,5481,561915.35
Short-Term Investments
-----70.21
Trading Asset Securities
210.53827.66150.96366.89422.41,179
Cash & Short-Term Investments
662.811,1441,6121,9151,9832,164
Cash Growth
-40.27%-29.03%-15.85%-3.41%-8.38%-14.52%
Accounts Receivable
893.96852.02612.58509.57510.67379.93
Other Receivables
46.6455.2651.4459.13103.8153.36
Receivables
940.6907.27664.02568.7614.47433.29
Inventory
783.7792.72652.69773.7677.69500.76
Prepaid Expenses
-3.363.72.520.812.23
Other Current Assets
755.7657.5421.5620.8817.8224.35
Total Current Assets
3,1432,9053,3543,2813,2943,125
Property, Plant & Equipment
2,0582,1882,3001,6321,2971,079
Long-Term Investments
549.622,1611,1241,134882.21681.06
Goodwill
348.48348.48348.48348.48348.48257.89
Other Intangible Assets
388.69382.26401.26418.59157150.77
Long-Term Deferred Tax Assets
77.2583.5680.9875.1168.6443.97
Long-Term Deferred Charges
43.3958.7321.226.7155.9574.03
Other Long-Term Assets
1,371351.9356.72446.73443.95254.71
Total Assets
7,9798,4797,9877,3636,5475,666
Accounts Payable
792.97880.79941.16719.12449.79369.05
Accrued Expenses
150.75198.28206.39187.72189.47181.44
Short-Term Debt
215281.36279.09238.58148.33300.13
Current Portion of Long-Term Debt
---0.050.27-
Current Portion of Leases
6.813.311.8614.6914.66-
Current Income Taxes Payable
68.9989.1844.359.9950.2556.06
Current Unearned Revenue
53.8856.4853.3581.0147.6148.14
Other Current Liabilities
651.44615.12538.61514.23521.88592.04
Total Current Liabilities
1,9402,1352,0751,8151,4221,547
Long-Term Debt
----0.040.65
Long-Term Leases
23.9123.1331.2342.9830.62-
Long-Term Unearned Revenue
267.57264.59268.81270.6128.73138.7
Long-Term Deferred Tax Liabilities
60.7554.3368.459.6865.4446.55
Other Long-Term Liabilities
1.061.193.21.940.740.82
Total Liabilities
2,2932,4782,4462,1911,6481,734
Common Stock
861.03861.03861.03861.03905.32705.51
Additional Paid-In Capital
1,7231,7231,7231,7202,2361,897
Retained Earnings
3,6593,3682,9142,5542,1501,766
Treasury Stock
-608.78----437.62-458.13
Comprehensive Income & Other
17.0617.1713.8611.318.056.37
Total Common Equity
5,6515,9705,5125,1464,8623,918
Minority Interest
34.1532.0427.7825.8537.7215.07
Shareholders' Equity
5,6866,0025,5405,1724,8993,933
Total Liabilities & Equity
7,9798,4797,9877,3636,5475,666
Total Debt
245.71317.79322.18296.3193.92300.77
Net Cash (Debt)
417.1826.131,2901,6191,7891,864
Net Cash Growth
-42.20%-35.94%-20.35%-9.51%-4.00%-14.22%
Net Cash Per Share
0.500.961.501.882.192.34
Filing Date Shares Outstanding
813.76861.03861.03861.03861.03807.73
Total Common Shares Outstanding
813.76861.03861.03861.03861.03807.73
Working Capital
1,203770.261,2791,4661,8721,578
Book Value Per Share
6.946.936.405.985.654.85
Tangible Book Value
4,9145,2394,7634,3794,3563,509
Tangible Book Value Per Share
6.046.085.535.095.064.34
Land
--0.21-0.21---
Buildings
-1,6291,388934.82889.16752.75
Machinery
-1,7541,4121,219946.45803.63
Construction In Progress
-13.62482.06284.91161.34139.84
Source: S&P Global Market Intelligence. Standard template. Financial Sources.